Skip to content

Author

O. Markova

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

RESULTS OF A PROSPECTIVE MULTICENTER OPEN-LABEL OBSERVATIONAL STUDY OF ENZYME REPLACEMENT THERAPY WITH AN IMIGLUCERASE BIOSIMILAR IN CHILDREN WITH TYPE 1 GAUCHER DISEASE

Enzyme replacement therapy (ERT) is the mainstay for type 1 Gaucher disease (GD1) treatment. Imiglucerase biosimilar usage allows to control GD1 manifestations and improve the patients’ life quality according to interventional clinical studies. Objective: To evaluate the results of Glurazyme® use during long-term ERT i...

G. Movsisyan, A. S. Potapov, Y. Dinikina et al. · 0 citations
#protein folding Open access Sep 2026

Pre-Seasonal Treatment With Recombinant Carrier-Based Birch Vaccine Improves Birch Pollen Allergy.

BACKGROUND We have recently reported the preclinical characterization of a recombinant birch pollen allergy vaccine based on a fusion protein, AB-PreS, consisting of allergen-derived peptides fused to the hepatitis B virus (HBV)-derived PreS surface protein as immunological carrier. OBJECTIVE To investigate in a clin...

M. Khaitov, M. Byazrova, E. Smolnikov et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.